VETIVEX HYPERTONIC SALINE SOLUTION 7.2%, USP

Manufacturer
Dechra Veterinary Products | Dechra Ltd
Effective date
2021-11-19
Label type
PRESCRIPTION ANIMAL DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:41:09

Label at a glance#

ProductVetivex Veterinary Hypertonic
Active ingredientSODIUM CHLORIDE
Label structure14 sections

Indications and uses

For use in replacement therapy of sodium, chloride and water which may become depleted in many diseases.

Dosage and administration

Warm to body temperature and administer slowly by intravenous or subcutaneous injection. The amount and rate of administration must be judged by the veterinarian in relation to the condition being treated and the clinical response of the animal, being careful to avoid overhydration.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

For Animal Use Only

Description:

DESCRIPTION SECTION

Veterinary Hypertonic Saline Solution 7.2%, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for parenteral administration. It contains no antimicrobial agents. Discard unused portion.

Table 1 Hypertonic saline solution 7.2%, USP
Size
(mL)
Sodium Chlorine
(mg/mL)
Osmolarity
(mEq/L)
pHSodium
(mEq/L)
Chloride
(mEq/L)
100072002464(4.5 -7.0)12321232

Clinical Pharmacology:

CLINICAL PHARMACOLOGY SECTION

Veterinary Hypertonic saline solutions 7.2%, USP has value as a source of water, electrolytes and calories.

Indications and Usage:

VETERINARY INDICATIONS SECTION

For use in replacement therapy of sodium, chloride and water which may become depleted in many diseases.

Warnings:

WARNINGS SECTION

This product contains no preservatives. Use entire contents when first opened. Discard any unused solution.

The parenteral administration of Veterinary Hypertonic saline solution 7.2%, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injection.

In patients with diminished renal function, administration of Veterinary Hypertonic saline solution 7.2%, USP may result in sodium retention.

Adverse reactions:

ADVERSE REACTIONS SECTION

Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.

Precautions:

PRECAUTIONS SECTION

Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.

Caution must be exercised in the administration of Veterinary HYPERTONIC SALINE SOLUTION 7.2%, USP to patients receiving corticosteroids or corticotropin. Do not administer unless solution is clear, and seal is intact.

Dosage and administration:

DOSAGE & ADMINISTRATION SECTION

Warm to body temperature and administer slowly by intravenous or subcutaneous injection. The amount and rate of administration must be judged by the veterinarian in relation to the condition being treated and the clinical response of the animal, being careful to avoid overhydration.

Overdosage:

OVERDOSAGE SECTION

In an event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures.

See Warnings, Adverse Reactions and Precautions.

How Supplied:

HOW SUPPLIED SECTION

HYPERTONIC SALINE SOLUTION 7.2%, USP is supplied in plastic bags as follows:

NDCVolume
17033-502-01      1000 mL

STORAGE AND HANDLING SECTION

Storage:

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored in the moisture barrier overwrap at room temperature of (15°C - 30°C) OR (59°F - 86°F). Keep out of reach of children, store between

Directions for use of plastic container

INSTRUCTIONS FOR USE SECTION

To open:

SPL UNCLASSIFIED SECTION

Tear overwrap downside at slit and remove solution bag. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired. If supplemental medication is desired, follow directions below.

Preparation for Administration:

SPL UNCLASSIFIED SECTION

  1. Suspend container from eyelet support.
  2. Remove protector from outlet port at bottom of container.
  3. Attach administration set. Refer to complete directions accompanying set.

To Add Medication

SPL UNCLASSIFIED SECTION

WARNING: Additives may be incompatible.

SPL UNCLASSIFIED SECTION

To add medication before solution administration:

  1. Prepare medication site.
  2. Using syringe with 19 to 22-gauge needle, puncture resealable medication port and inject.
  3. Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.
SPL UNCLASSIFIED SECTION

To add medication during solution administration:

  1. Close clamp on the administration set to stop the flow to the patient.
  2. Prepare medication site.
  3. Using syringe with 19 to 22-gauge needle, puncture resealable medication port and inject.
  4. Remove container from IV pole and/or turn to an upright position.
  5. Evacuate both ports by squeezing them while container is in the upright position.
  6. Mix solution and medication thoroughly.
  7. Return container to in-use position and continue administration.

SPL UNCLASSIFIED SECTION

CAUTION: Federal law (U.S.A.) restricts this drug to use by or on the order of a licensed veterinarian.

SPL UNCLASSIFIED SECTION

DISTRIBUTED BY:
Dechra Veterinary Products
7015 College Boulevard, Suite 525 Overland Park, KS 66211
Made in El Salvador.
For a copy of the Safety Data Sheet (SDS) or to report adverse reactions call
Dechra Veterinary Products at (866) 933-2472.
© 2021 Dechra Ltd.
Vetivex is a trademark of Dechra Ltd; all rights reserved.
REV07/21

PRINCIPAL DISPLAY PANEL - 1000 mL Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Vetivex®

Hypertonic Saline
Solution 7.2%, USP

STERILE - NONPYROGENIC SOLUTION
FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN
CAUTION: FEDERAL LAW (U.S.A.) RESTRICTS
THIS DRUG TO USE BY OR ON THE ORDER OF A
LICENCED VETERINARIAN.
NDC: 17033-502-01

INDICATIONS:

FOR USE IN REPLACEMENT THERAPY OF SODIUM, CHLORIDE
AND WATER WHICH MAY BECOME DEPLETED IN MANY DISEASES.

DOSAGE AND ADMINISTRATION:

HORSES / CATTLE: 50 TO 100 ML PER 100 LB BODY
WEIGHT. WARM TO BODY TEMPERATURE AND ADMINISTER
SLOWLY BY INTRAVENOUS OR SUBCUTANEOUS INJECTION.
THE AMOUNT AND RATE OF ADMINISTRATION MUST BE
JUDGED BY THE VETERINARIAN IN RELATION TO THE
CONDITION BEING TREATED AND THE CLINICAL RESPONSE OF
THE ANIMAL, BEING CAREFUL TO AVOID OVERHYDRATION.

COMPOSITION:

EACH 100 mL OF STERILE AQUEOUS SOLUTION CONTAINS 7.2 g
OF SODIUM CHLORIDE.

MILLIEQUIVALENTS PER LITER:

CATIONS 1,232 mEq - ANIONS 1,232 mEq/L
TOTAL OSMOLARITY IS 2,464 MILLIOSMOLES PER LITER.
PH 4.5 - 7.0

WARNING: THIS PRODUCT CONTAINS NO PRESERVATIVES.
USE ENTIRE CONTENTS WHEN FIRST OPENED. DISCARD
ANY UNUSED SOLUTION.

STORAGE: EXPOSURE OF PHARMACEUTICAL PRODUCTS
TO HEAT SHOULD BE MINIMIZED. AVOID EXCESSIVE HEAT.
IT IS RECOMMENDED THE PRODUCT BE STORED IN
MOISTURE BARRIER OVERWRAP AT ROOM TEMPERATURE
(25°C/77°F); BRIEF EXPOSURE UP TO 40°C/104°F DOES
NOT ADVERSELY AFFECT THE PRODUCT.

DISTRIBUTED BY:
DECHRA VETERINARY PRODUCTS
7015 COLLEGE BOULEVARD, SUITE 525,
OVERLAND PARK, KS 66211

MADE IN EL SALVADOR
STERILE

TAKE
TIME
OBSERVE LABEL
DIRECTIONS

Rev. 05/21

1000 mL
Dechra

LOT.0000000 EXP.00/0000

PRINCIPAL DISPLAY PANEL - 1000 mL Container Label
PRINCIPAL DISPLAY PANEL - 1000 mL Container Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1149629sodium chloride 7.2 % in 1000 ML InjectionPSN2
11496291000 ML sodium chloride 72 MG/ML InjectionSCD2
11496291000 ML NaCl 72 MG/ML InjectionSY2
1149629sodium chloride 7.2 % per 1000 ML InjectionSY2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
95250459-30e4-45c1-b08a-993044f49109Product name220250805
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2Product name520250304
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
a21a21e5-f36d-4c1f-8918-def921b8f7e3Product name320250124
bed0530e-f939-4541-956b-6928a2f6404fProduct name120241008
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name620240814
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name220171212
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17033-502-01Vetivex Veterinary Hypertonic1000 mL in 1 CONTAINERINJECTION, SOLUTION10002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17033-502VETIVEX VETERINARY HYPERTONIC (SODIUM CHLORIDE) INJECTION, SOLUTION [DECHRA VETERINARY PRODUCTS]21 package rows20211201_9b2c542f-80c7-401d-a731-929179853b2b.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
17033-50217033-502-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
SODIUM CHLORIDE451W47IQ8XACTIB
WATER059QF0KO0RIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 9 · 180 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BiologixCare Sterile Saline Wound WashSODIUM CHLORIDEBIOLOGIX USA, INC.5e74e26d-fe34-8784-e063-6394a90ae1942026-10-29WarningsName fallback
generic name: SODIUM CHLORIDE
BiologixCare Sterile Saline Wound WashSODIUM CHLORIDEBIOLOGIX USA, INC.5ed79ba5-43a0-c323-e063-6394a90a46182026-10-29WarningsName fallback
generic name: SODIUM CHLORIDE
BiologixCare Sterile Saline Wound WashSODIUM CHLORIDEBIOLOGIX USA, INC.5eda970a-6fe4-8af3-e063-6394a90a57622026-10-29WarningsName fallback
generic name: SODIUM CHLORIDE
BiologixCare Sterile Saline Wound WashSODIUM CHLORIDEBIOLOGIX USA, INC.5edb1f1e-122d-f0da-e063-6394a90a4ccd2026-10-29WarningsName fallback
generic name: SODIUM CHLORIDE
BiologixCare Sterile Saline Wound WashSODIUM CHLORIDEBIOLOGIXUSA, INC.5ede6a14-cc47-8423-e063-6294a90a58c52026-10-29WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDECardinal Health 107, LLC97007188-43fe-416c-a87b-6ccc4d9ae2ec2026-10-28Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
QUALITY CHOICE SALINESODIUM CHLORIDEQUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)f51491d8-12ad-4b1b-a171-c621bfdcc3412026-10-28WarningsName fallback
generic name: SODIUM CHLORIDE
Normal SaltSODIUM CHLORIDEGRAXCELL PHARMACEUTICAL, LLCf3f09817-8a38-4aa1-956b-69d9cf6950742026-10-26WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDECODAN US CORPORATIONaa06e286-75c6-4d7a-959f-6008d38aa6e52026-10-08Warnings, Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDENextgen Pharmaceuticals LLC28f79c75-82d2-4912-81fc-a723b5ccf4c12026-10-08Warnings, Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDESOLA Pharmaceuticals, LLC4d0bfd28-460a-48ba-bd17-cf75e56d62f42026-10-08Warnings, Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDELABORATORIOS GRIFOLS SAeb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf2026-10-08Warnings, Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
Personal CARE Saline NasalSODIUM CHLORIDEDelta Brands Inc.5ccaf7a1-6891-eac4-e063-6294a90a829f2026-10-02WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium Chloride Hypertonicity OphthalmicSODIUM CHLORIDERugby Laboratories7546770d-bc12-44b8-9fe0-fc3f5e1d12d12026-09-24WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium Chlorode Hypertonicity Ophthalmic SolutionSODIUM CHLORIDERugby Laboratories822d25c0-71b3-421d-b702-4cded0c4ca322026-09-23WarningsName fallback
generic name: SODIUM CHLORIDE
BURBLESODIUM CHLORIDELETS BURBLE, INC.17f48d4f-907c-3829-e063-6394a90ab2022026-09-22WarningsName fallback
generic name: SODIUM CHLORIDE
Nacl 0.9% Normal Saline SolutionSODIUM CHLORIDECHI FUNG TECHNOLOGY COMPANY5a53c4c8-c9de-700c-e063-6394a90a3ab52026-08-31WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDEYYBA CORP597f3347-647c-3545-e063-6294a90abab22026-08-20WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDEFresenius Kabi USA, LLC2e5fe9f4-78e5-4af4-8bf9-9680e5dc5e882026-08-20Warnings, Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
Hypertonic SalineSODIUM CHLORIDENAVEH PHARMA (1996) LTD167c7a9c-1228-4fb2-a89c-d3e1483863232026-07-30WarningsName fallback
generic name: SODIUM CHLORIDE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.